REG - Barclays PLC - Publication of a Prospectus

BarclaysAnnouncement

26/04/2024 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240426:nRSZ2764Ma&default-theme=true

RNS Number : 2764M  Barclays PLC  26 April 2024

Publication of Base Prospectus Supplement dated 26 April 2024

The following base prospectus supplement ("Prospectus Supplement") has been
approved by the Financial Conduct Authority and is available for viewing:

Prospectus Supplement dated 26 April 2024 to the Base Prospectus dated 13
March 2024 for the Barclays PLC Debt Issuance Programme ("Base Prospectus").

Please read the disclaimer below "Disclaimer - Intended Addressees" before
attempting to access this service, as your right to do so is conditional upon
complying with the requirements set out below.

To view the full document, please paste the following URL into the address bar
of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/2764M_1-2024-4-26.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2764M_1-2024-4-26.pdf)

A copy of the above document has been submitted to the National Storage
Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

For further information, please contact:

Barclays Treasury

1 Churchill Place

Canary Wharf

London E14 5HP

 

DISCLAIMER - INTENDED ADDRESSEES

IMPORTANT: You must read the following before continuing: The following
applies to the Prospectus Supplement available by clicking on the link above,
and you are therefore advised to read this carefully before reading, accessing
or making any other use of the Prospectus Supplement. In accessing the
Prospectus Supplement, you agree to be bound by the following terms and
conditions, including any modifications to them, any time you receive any
information from us as a result of such access.

THE PROSPECTUS SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS
PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE
PROSPECTUS SUPPLEMENT MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO
PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE ON,
REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT") OR WITHIN THE UNITED STATES TO QIBs (AS DEFINED BELOW) IN
ACCORDANCE WITH RULE 144A UNDER THE SECURITIES ACT ("RULE 144A"). ANY
FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE PROSPECTUS SUPPLEMENT IN WHOLE
OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A
VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.

NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES FOR
SALE IN ANY JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE
BASE PROSPECTUS AND THE PROSPECTUS SUPPLEMENT HAVE NOT BEEN, AND WILL NOT BE,
REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OF THE
UNITED STATES OR ANY OTHER JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED
PURSUANT TO THE BASE PROSPECTUS AND PROSPECTUS SUPPLEMENT MAY NOT BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) IN ACCORDANCE WITH RULE 144A
UNDER THE SECURITIES ACT TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED
INSTITUTIONAL BUYERS (EACH A "QIB") WITHIN THE MEANING OF RULE 144A OR (2) IN
AN OFFSHORE TRANSACTION TO A PERSON THAT IS NOT A U.S. PERSON IN ACCORDANCE
WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT.

Please note that the information contained in the Base Prospectus and the
Prospectus Supplement may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Base Prospectus) only and
is not intended for use and should not be relied upon by any person outside
these countries and/or to whom the offer contained in the Prospectus
Supplement is not addressed. Prior to relying on the information contained in
the Base Prospectus and the Prospectus Supplement you must ascertain from the
Base Prospectus whether or not you are part of the intended addressees of the
information contained therein.

Confirmation of your Representation: In order to be eligible to view the
Prospectus Supplement or make an investment decision with respect to any Notes
issued or to be issued pursuant to the Base Prospectus and the Prospectus
Supplement, you must be (i) a person other than a U.S. person (within the
meaning of Regulation S under the Securities Act); or (ii) a QIB that is
acquiring the securities for its own account or for the account of another
QIB. By accessing the Prospectus Supplement, you shall be deemed to have
represented that you and any customers you represent are not U.S. persons
(within the meaning of Regulation S under the Securities Act) or that you are
a QIB, and that you consent to delivery of the Prospectus Supplement and any
supplements thereto via electronic publication.

You are reminded that the Prospectus Supplement has been made available to you
on the basis that you are a person into whose possession the Prospectus
Supplement may be lawfully delivered in accordance with the laws of the
jurisdiction in which you are located and you may not, nor are you authorised
to, deliver the Prospectus Supplement to any other person.

The Prospectus Supplement does not constitute, and may not be used in
connection with, an offer or solicitation in any place where offers or
solicitations are not permitted by law. If a jurisdiction requires that the
offering be made by a licensed broker or dealer and the underwriters or any
affiliate of the underwriters is a licensed broker or dealer in that
jurisdiction, the offering shall be deemed to be made by the underwriters or
such affiliate on behalf of Barclays PLC in such jurisdiction. Under no
circumstances shall the Prospectus Supplement constitute an offer to sell, or
the solicitation of an offer to buy, nor shall there be any sale of any Notes
issued or to be issued pursuant to the Base Prospectus and the Prospectus
Supplement, in any jurisdiction in which such offer, solicitation or sale
would be unlawful.

The Prospectus Supplement has been made available to you in an electronic
form. You are reminded that documents transmitted via this medium may be
altered or changed during the process of electronic transmission and
consequently none of Barclays PLC, its advisers nor any person who controls
any of them nor any director, officer, employee nor agent of it or affiliate
of any such person accepts any liability or responsibility whatsoever in
respect of any difference between the Prospectus Supplement made available to
you in electronic format and the hard copy version available to you as set out
in the Prospectus Supplement.

Your right to access this service is conditional upon complying with the above
requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDIEALLKAAALEFA